211 related articles for article (PubMed ID: 24058690)
21. Analysis of serum FSH bioactivity in a patient with an FSH-secreting pituitary microadenoma and multicystic ovaries: A case report.
Kajitani T; Liu S; Maruyama T; Uchida H; Sakurai R; Masuda H; Nagashima T; Ono M; Arase T; Yoshimura Y
Hum Reprod; 2008 Feb; 23(2):435-9. PubMed ID: 18056718
[TBL] [Abstract][Full Text] [Related]
22. Spontaneous ovarian hyperstimulation syndrome.
Kasum M; Oresković S; Jezek D
Coll Antropol; 2013 Jun; 37(2):653-6. PubMed ID: 23941020
[TBL] [Abstract][Full Text] [Related]
23. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2004 Apr; 89(4):1255-8. PubMed ID: 15080154
[TBL] [Abstract][Full Text] [Related]
24. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2004 Mar; 89(3):1255-8. PubMed ID: 15001619
[TBL] [Abstract][Full Text] [Related]
25. Role of FSH and FSH receptor on HUVECs migration.
Tan D; Zhao Y; Ma D; Tong F
Gene Ther; 2021 Apr; 28(3-4):155-161. PubMed ID: 32994568
[TBL] [Abstract][Full Text] [Related]
26. Structural determinants in the second intracellular loop of the human follicle-stimulating hormone receptor are involved in G(s) protein activation.
Timossi C; Maldonado D; Vizcaíno A; Lindau-Shepard B; Conn PM; Ulloa-Aguirre A
Mol Cell Endocrinol; 2002 Mar; 189(1-2):157-68. PubMed ID: 12039074
[TBL] [Abstract][Full Text] [Related]
27. Functional and clinical consequences of mutations in the FSH receptor.
Gromoll J; Simoni M; Nordhoff V; Behre HM; De Geyter C; Nieschlag E
Mol Cell Endocrinol; 1996 Dec; 125(1-2):177-82. PubMed ID: 9027356
[TBL] [Abstract][Full Text] [Related]
28. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.
Touraine P; Beau I; Gougeon A; Meduri G; Desroches A; Pichard C; Detoeuf M; Paniel B; Prieur M; Zorn JR; Milgrom E; Kuttenn F; Misrahi M
Mol Endocrinol; 1999 Nov; 13(11):1844-54. PubMed ID: 10551778
[TBL] [Abstract][Full Text] [Related]
29. Identification and in vitro characterization of follicle stimulating hormone (FSH) receptor variants associated with abnormal ovarian response to FSH.
Gerasimova T; Thanasoula MN; Zattas D; Seli E; Sakkas D; Lalioti MD
J Clin Endocrinol Metab; 2010 Feb; 95(2):529-36. PubMed ID: 20061434
[TBL] [Abstract][Full Text] [Related]
30. Follicular Stimulating Hormone Accelerates Atherogenesis by Increasing Endothelial VCAM-1 Expression.
Li X; Chen W; Li P; Wei J; Cheng Y; Liu P; Yan Q; Xu X; Cui Y; Gu Z; Simoncini T; Fu X
Theranostics; 2017; 7(19):4671-4688. PubMed ID: 29187895
[No Abstract] [Full Text] [Related]
31. Genetic complexity of FSH receptor function.
Gromoll J; Simoni M
Trends Endocrinol Metab; 2005 Oct; 16(8):368-73. PubMed ID: 16126408
[TBL] [Abstract][Full Text] [Related]
32. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome.
Rizk B
Reprod Biomed Online; 2009 Jul; 19(1):14-27. PubMed ID: 19573286
[TBL] [Abstract][Full Text] [Related]
33. An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice.
Haywood M; Tymchenko N; Spaliviero J; Koch A; Jimenez M; Gromoll J; Simoni M; Nordhoff V; Handelsman DJ; Allan CM
Mol Endocrinol; 2002 Nov; 16(11):2582-91. PubMed ID: 12403847
[TBL] [Abstract][Full Text] [Related]
34. Toward gene therapy of primary ovarian failure: adenovirus expressing human FSH receptor corrects the Finnish C566T mutation.
Ghadami M; Salama SA; Khatoon N; Chilvers R; Nagamani M; Chedrese PJ; Al-Hendy A
Mol Hum Reprod; 2008 Jan; 14(1):9-15. PubMed ID: 18084009
[TBL] [Abstract][Full Text] [Related]
35. Functional characterization of two naturally occurring mutations V
Banerjee AA; Achrekar SK; Joseph S; Pathak BR; Mahale SD
Mol Cell Endocrinol; 2017 Jan; 440():69-79. PubMed ID: 27889471
[TBL] [Abstract][Full Text] [Related]
36. FSHR antagonists can trigger a PCOS-like state.
Waghu FH; Desai K; Srinivasan S; Prabhudesai KS; Dighe V; Venkatesh KV; Idicula-Thomas S
Syst Biol Reprod Med; 2022 Apr; 68(2):129-137. PubMed ID: 34967272
[TBL] [Abstract][Full Text] [Related]
37. Preferential β-arrestin signalling at low receptor density revealed by functional characterization of the human FSH receptor A189 V mutation.
Tranchant T; Durand G; Gauthier C; Crépieux P; Ulloa-Aguirre A; Royère D; Reiter E
Mol Cell Endocrinol; 2011 Jan; 331(1):109-18. PubMed ID: 20801186
[TBL] [Abstract][Full Text] [Related]
38. The molecular basis of impaired follicle-stimulating hormone action: evidence from human mutations and mouse models.
Siegel ET; Kim HG; Nishimoto HK; Layman LC
Reprod Sci; 2013 Mar; 20(3):211-33. PubMed ID: 23184658
[TBL] [Abstract][Full Text] [Related]
39. Follicle-Stimulating Hormone Induces Lipid Droplets
Sayers NS; Anujan P; Yu HN; Palmer SS; Nautiyal J; Franks S; Hanyaloglu AC
Front Endocrinol (Lausanne); 2021; 12():798866. PubMed ID: 35185785
[TBL] [Abstract][Full Text] [Related]
40. A case of ovarian torsion in a patient carrier of a FSH receptor gene mutation previously affected by spontaneous ovarian hyperstimulation syndrome.
Di Carlo C; Savoia F; Fabozzi A; Gargano V; Nappi C
Gynecol Endocrinol; 2015 Feb; 31(2):105-8. PubMed ID: 25495063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
